Avant Brands Inc. (AVNT.TO)
CAD 0.95
(0.0%)
CAD 0.95
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 33.22 Million CAD | 76.84% |
| 2022 | 18.78 Million CAD | 596.88% |
| 2021 | 2.69 Million CAD | -78.22% |
| 2020 | 12.38 Million CAD | 38.99% |
| 2019 | 8.9 Million CAD | 15.32% |
| 2018 | 7.72 Million CAD | 17397.38% |
| 2017 | 44.14 Thousand CAD | -90.26% |
| 2016 | 453.01 Thousand CAD | 29.84% |
| 2015 | 348.89 Thousand CAD | -32.92% |
| 2014 | 520.15 Thousand CAD | 4030.16% |
| 2013 | 12.59 Thousand CAD | -68.34% |
| 2012 | 39.78 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 28.44 Million CAD | -10.37% |
| 2024 Q3 | 26.47 Million CAD | -6.91% |
| 2024 Q1 | 31.73 Million CAD | -4.48% |
| 2023 FY | 33.22 Million CAD | 76.84% |
| 2023 Q2 | 21.53 Million CAD | -1.9% |
| 2023 Q3 | 29.53 Million CAD | 37.17% |
| 2023 Q1 | 21.94 Million CAD | 16.82% |
| 2023 Q4 | 33.22 Million CAD | 12.49% |
| 2022 Q1 | 2.75 Million CAD | 2.23% |
| 2022 FY | 18.78 Million CAD | 596.88% |
| 2022 Q4 | 18.78 Million CAD | 13.28% |
| 2022 Q3 | 16.58 Million CAD | 369.59% |
| 2022 Q2 | 3.53 Million CAD | 28.16% |
| 2021 Q1 | 9.95 Million CAD | -19.63% |
| 2021 FY | 2.69 Million CAD | -78.22% |
| 2021 Q4 | 2.69 Million CAD | -8.08% |
| 2021 Q3 | 2.93 Million CAD | 0.2% |
| 2021 Q2 | 2.92 Million CAD | -70.58% |
| 2020 Q2 | 10.53 Million CAD | 6.09% |
| 2020 FY | 12.38 Million CAD | 38.99% |
| 2020 Q4 | 12.38 Million CAD | 15.03% |
| 2020 Q3 | 10.76 Million CAD | 2.15% |
| 2020 Q1 | 9.93 Million CAD | 11.5% |
| 2019 Q2 | 7.64 Million CAD | -9.2% |
| 2019 Q3 | 8.58 Million CAD | 12.34% |
| 2019 FY | 8.9 Million CAD | 15.32% |
| 2019 Q1 | 8.41 Million CAD | 8.97% |
| 2019 Q4 | 8.9 Million CAD | 3.75% |
| 2018 Q1 | 23.86 Thousand CAD | -45.93% |
| 2018 FY | 7.72 Million CAD | 17397.38% |
| 2018 Q4 | 7.72 Million CAD | 17.44% |
| 2018 Q3 | 6.57 Million CAD | 97.19% |
| 2018 Q2 | 3.33 Million CAD | 13873.51% |
| 2017 Q2 | 429.88 Thousand CAD | -2.27% |
| 2017 Q1 | 439.88 Thousand CAD | -2.9% |
| 2017 FY | 44.14 Thousand CAD | -90.26% |
| 2017 Q4 | 44.14 Thousand CAD | -11.87% |
| 2017 Q3 | 50.08 Thousand CAD | -88.35% |
| 2016 Q1 | 346.7 Thousand CAD | -0.63% |
| 2016 Q2 | 288.91 Thousand CAD | -16.67% |
| 2016 Q4 | 453.01 Thousand CAD | 59.59% |
| 2016 Q3 | 283.86 Thousand CAD | -1.75% |
| 2016 FY | 453.01 Thousand CAD | 29.84% |
| 2015 Q3 | 382.97 Thousand CAD | -6.47% |
| 2015 FY | 348.89 Thousand CAD | -32.92% |
| 2015 Q4 | 348.89 Thousand CAD | -8.9% |
| 2015 Q1 | 526.9 Thousand CAD | 1.3% |
| 2015 Q2 | 409.46 Thousand CAD | -22.29% |
| 2014 Q4 | 520.15 Thousand CAD | 696.3% |
| 2014 FY | 520.15 Thousand CAD | 4030.16% |
| 2014 Q1 | 12 Thousand CAD | -4.67% |
| 2014 Q3 | 65.32 Thousand CAD | 49.09% |
| 2014 Q2 | 43.81 Thousand CAD | 264.92% |
| 2013 Q4 | 12.59 Thousand CAD | 0.0% |
| 2013 Q1 | 46.3 Thousand CAD | 0.0% |
| 2013 FY | 12.59 Thousand CAD | -68.34% |
| 2013 Q2 | 46.3 Thousand CAD | 0.0% |
| 2013 Q3 | - CAD | -100.0% |
| 2012 FY | 39.78 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aurora Cannabis Inc. | 236.8 Million CAD | 85.97% |
| Avicanna Inc. | 13.99 Million CAD | -137.331% |
| Cardiol Therapeutics Inc. | 8.45 Million CAD | -292.997% |
| Crescita Therapeutics Inc. | 5.77 Million CAD | -475.208% |
| Knight Therapeutics Inc. | 198.62 Million CAD | 83.273% |
| MediPharm Labs Corp. | 10.93 Million CAD | -203.915% |
| OrganiGram Holdings Inc. | 26.83 Million CAD | -23.822% |
| Canopy Growth Corporation | 799.82 Million CAD | 95.846% |
| Willow Biosciences Inc. | 3.23 Million CAD | -926.382% |
| Auxly Cannabis Group Inc. | 210.85 Million CAD | 84.243% |